Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Racial disparities in survival rates among patients with multiple myeloma and diabetes

Racial disparities in survival rates among patients with multiple myeloma and diabetes

Creating CAR-T cells with enhanced immune memory to fight cancer

Creating CAR-T cells with enhanced immune memory to fight cancer

Annual NCCN Congress to focus on latest advances in blood cancer treatment

Annual NCCN Congress to focus on latest advances in blood cancer treatment

Study reveals potential targets to improve the treatment of myeloma

Study reveals potential targets to improve the treatment of myeloma

NCCN publishes new guideline focused on preventing and treating cancer-associated blood clots

NCCN publishes new guideline focused on preventing and treating cancer-associated blood clots

Immune system plays key role in determining the duration of patients' remission from multiple myeloma

Immune system plays key role in determining the duration of patients' remission from multiple myeloma

Universal approach could potentially expand CAR T cell therapy to all blood cancers

Universal approach could potentially expand CAR T cell therapy to all blood cancers

New oral agent shows promise in treatment of relapsed multiple myeloma

New oral agent shows promise in treatment of relapsed multiple myeloma

Midnolin protein plays key role in breaking down short-lived nuclear proteins

Midnolin protein plays key role in breaking down short-lived nuclear proteins

Associations between alcohol intake, cancer risk, and modifying factors in women: smoking, BMI, and MHT interactions

Associations between alcohol intake, cancer risk, and modifying factors in women: smoking, BMI, and MHT interactions

A peek at Big Pharma’s playbook that leaves many Americans unable to afford their drugs

A peek at Big Pharma’s playbook that leaves many Americans unable to afford their drugs

How conversion between different types of cell death contributes to disease

How conversion between different types of cell death contributes to disease

Using 'click chemistry' to create novel multi-protein anti-cancer agents

Using 'click chemistry' to create novel multi-protein anti-cancer agents

WHO to declare artificial sweetener aspartame as possible carcinogen

WHO to declare artificial sweetener aspartame as possible carcinogen

Study offers novel insights into the evolution of multiple myeloma

Study offers novel insights into the evolution of multiple myeloma

Cancer patients can initiate SARS-CoV-2 vaccination three months after bone marrow transplant

Cancer patients can initiate SARS-CoV-2 vaccination three months after bone marrow transplant

Metabolically healthy and unhealthy 'forms' of obesity linked with increased risk of obesity-related cancers

Metabolically healthy and unhealthy 'forms' of obesity linked with increased risk of obesity-related cancers

Targeting the hemoglobin problem in sickle cell disease using a new drug

Targeting the hemoglobin problem in sickle cell disease using a new drug

Testing hundreds of existing therapeutics to fight blood cancer more effectively

Testing hundreds of existing therapeutics to fight blood cancer more effectively

First-in-human clinical study begins investigating the duoCAR T-cell therapy for treatment of HIV

First-in-human clinical study begins investigating the duoCAR T-cell therapy for treatment of HIV

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.